121 related articles for article (PubMed ID: 1974290)
1. Pharmacokinetics, bioavailability, metabolism, tissue distribution and urinary excretion of gamma-L-glutamyl-L-dopa in the rat.
Cummings J; Matheson LM; Maurice L; Smyth JF
J Pharm Pharmacol; 1990 Apr; 42(4):242-6. PubMed ID: 1974290
[TBL] [Abstract][Full Text] [Related]
2. The renal handling of dopamine originating from L-dopa and gamma-glutamyl-L-dopa.
Pestana M; Soares-da-Silva P
Br J Pharmacol; 1994 Jun; 112(2):417-22. PubMed ID: 8075859
[TBL] [Abstract][Full Text] [Related]
3. Renal metabolism and effects of the glutamyl derivatives of L-dopa and 5-hydroxytryptophan in man.
Li Kam Wa TC; Freestone S; Samson RR; Johnston NR; Lee MR
Clin Sci (Lond); 1996 Aug; 91(2):177-85. PubMed ID: 8795441
[TBL] [Abstract][Full Text] [Related]
4. Method for the determination of gamma-L-glutamyl-L-dihydroxyphenylalanine and its major metabolites L-dihydroxyphenylalanine, dopamine and 3,4-dihydroxyphenylacetic acid by high-performance liquid chromatography with electrochemical detection.
Cummings J; Matheson LM; Smyth JF
J Chromatogr; 1990 Jun; 528(1):43-53. PubMed ID: 2117019
[TBL] [Abstract][Full Text] [Related]
5. Effect of gamma-L-glutamyl-L-dopa on phosphate excretion.
Sadiq S; Berndt TJ; Nath KA; Knox FG
J Lab Clin Med; 2000 Jan; 135(1):52-6. PubMed ID: 10638694
[TBL] [Abstract][Full Text] [Related]
6. The pharmacokinetics of gamma-glutamyl-L-dopa in normal and anephric rats and rats with glycerol-induced acute renal failure.
Boateng YA; Barber HE; MacDonald TM; Petrie JC; Lee MR; Whiting PH
Br J Pharmacol; 1990 Oct; 101(2):301-6. PubMed ID: 2124159
[TBL] [Abstract][Full Text] [Related]
7. Disposition of gamma-glutamyl levodopa (gludopa) after intravenous bolus injection in healthy volunteers.
Boateng YA; Barber HE; MacDonald TM; Petrie JC; Lee MR
Br J Clin Pharmacol; 1991 Apr; 31(4):419-22. PubMed ID: 1904753
[TBL] [Abstract][Full Text] [Related]
8. Metabolism and vascular effects of gamma-L-glutamyl-L-dopa on the isolated rat kidney.
Barthelmebs M; Caillette A; Ehrhardt JD; Velly J; Imbs JL
Kidney Int; 1990 Jun; 37(6):1414-22. PubMed ID: 1972967
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the renal actions of gamma-L-glutamyl-L-dopa and gamma-L-glutamyl-L-tyrosine in normal man.
Jeffrey RF; MacDonald TM; Lee MR
Clin Sci (Lond); 1988 Jan; 74(1):37-40. PubMed ID: 3123118
[TBL] [Abstract][Full Text] [Related]
10. Suppression of noradrenaline spillover by the dopamine prodrug gamma-L-glutamyl-L-dopa: a central effect?
McGrath BP; Wang ZQ; Shimizu K; Way D; Secombe J
Hypertens Res; 1995 Jun; 18 Suppl 1():S113-8. PubMed ID: 8529039
[TBL] [Abstract][Full Text] [Related]
11. gamma-Glutamyl dopa: a kidney-specific dopamine precursor.
Wilk S; Mizoguchi H; Orlowski M
J Pharmacol Exp Ther; 1978 Jul; 206(1):227-32. PubMed ID: 660553
[TBL] [Abstract][Full Text] [Related]
12. gamma-L-glutamyl-L-DOPA inhibits Na(+)-phosphate cotransport across renal brush border membranes and increases renal excretion of phosphate.
de Toledo FG; Thompson MA; Bolliger C; Tyce GM; Dousa TP
Kidney Int; 1999 May; 55(5):1832-42. PubMed ID: 10231445
[TBL] [Abstract][Full Text] [Related]
13. The effect of carbidopa and indomethacin on the renal response to gamma-L-glutamyl-L-dopa in normal man.
Jeffrey RF; MacDonald TM; Marwick K; Lee MR
Br J Clin Pharmacol; 1988 Feb; 25(2):195-201. PubMed ID: 3129006
[TBL] [Abstract][Full Text] [Related]
14. BIA 3-202, a novel catechol-O-methyltransferase inhibitor, enhances the availability of L-DOPA to the brain and reduces its O-methylation.
Parada A; Loureiro AI; Vieira-Coelho MA; Hainzl D; Soares-da-Silva P
Eur J Pharmacol; 2001 May; 420(1):27-32. PubMed ID: 11412836
[TBL] [Abstract][Full Text] [Related]
15. Renal dopamine synthesis from precursors.
Barthelmebs M; Vailly B; Velly J; Ehrhardt JD; Grima M; Imbs JL
Am J Hypertens; 1990 Jun; 3(6 Pt 2):18S-21S. PubMed ID: 2116809
[TBL] [Abstract][Full Text] [Related]
16. Sympatho-inhibitory effects of r-l-glutamyl-l-dopa in conscious rabbits.
Wang ZQ; Shimizu K; Way D; Secombe J; McGrath BP
Zhongguo Yao Li Xue Bao; 1994 Jan; 15(1):17-21. PubMed ID: 8010078
[TBL] [Abstract][Full Text] [Related]
17. gamma-Glutamyl DOPA and gamma-glutamyl dopamine: effect on plasma glucose levels.
Mizoguchi H; Orlowski M; Wilk S; Green JP
Eur J Pharmacol; 1979 Aug; 57(2-3):239-45. PubMed ID: 488163
[TBL] [Abstract][Full Text] [Related]
18. [Metabolism and vascular effects of gammaglutamyl L-dopa on the isolated kidney of the rat].
Caillette A; Schmidt M; Ehrhardt JD; Imbs JL
Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():179-82. PubMed ID: 3142404
[TBL] [Abstract][Full Text] [Related]
19. Assessment of renal dopaminergic system activity during cyclosporine A administration in the rat.
Pestana M; Vieira-Coelho MA; Pinto-do-O PC; Fernandes MH; Soares-da-Silva P
Br J Pharmacol; 1995 Aug; 115(8):1349-58. PubMed ID: 8564191
[TBL] [Abstract][Full Text] [Related]
20. Sodium-dependence and ouabain-sensitivity of the synthesis of dopamine in renal tissues of the rat.
Soares-da-Silva P; Fernandes MH
Br J Pharmacol; 1992 Apr; 105(4):811-6. PubMed ID: 1504714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
